These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
926 related articles for article (PubMed ID: 18330513)
1. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513 [TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908 [TBL] [Abstract][Full Text] [Related]
5. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial. Pfeiffer P Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023 [TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
8. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434 [TBL] [Abstract][Full Text] [Related]
9. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. Hildebrandt B; Wust P; Dräger J; Lüdemann L; Sreenivasa G; Tullius SG; Amthauer H; Neuhaus P; Felix R; Riess H Int J Hyperthermia; 2004 Jun; 20(4):359-69. PubMed ID: 15204518 [TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose. Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881 [TBL] [Abstract][Full Text] [Related]
11. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial. Vestermark LW; Jensen HA; Pfeiffer P Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062 [TBL] [Abstract][Full Text] [Related]
12. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. Tepper JE; O'Connell M; Hollis D; Niedzwiecki D; Cooke E; Mayer RJ; J Clin Oncol; 2003 Oct; 21(19):3623-8. PubMed ID: 14512393 [TBL] [Abstract][Full Text] [Related]
13. Reirradiation of locally recurrent nasopharyngeal carcinoma. Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656 [TBL] [Abstract][Full Text] [Related]
19. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy. Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405 [TBL] [Abstract][Full Text] [Related]
20. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Strnad V; Geiger M; Lotter M; Sauer R Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]